fingolimod hydrochloride has been researched along with Cerebrovascular Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CP; Chew, WS; Chua, XY; Herr, DR; Ho, LTY; Lai, MKP; Lam, BWS; Ong, WY; Xiang, P | 1 |
| Berlit, P; Herold, M; Kraemer, M; Weber, R | 1 |
| Bourdette, D; Gilden, D | 1 |
| Calabresi, PA; Costello, K; Ratchford, JN; Reich, DS | 1 |
1 review(s) available for fingolimod hydrochloride and Cerebrovascular Disorders
| Article | Year |
|---|---|
Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment.
Topics: Aldehyde-Lyases; Alzheimer Disease; Animals; Cerebrovascular Disorders; Clinical Trials as Topic; Dementia, Vascular; Drug Delivery Systems; Drug Evaluation, Preclinical; Fingolimod Hydrochloride; Humans; Infarction, Middle Cerebral Artery; Inflammation; Ischemic Stroke; Lysophospholipids; Mice; Mice, Knockout; Neurodegenerative Diseases; Phosphotransferases (Alcohol Group Acceptor); Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors | 2021 |
3 other study(ies) available for fingolimod hydrochloride and Cerebrovascular Disorders
| Article | Year |
|---|---|
Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing-remitting multiple sclerosis three months after childbirth.
Topics: Adult; Cerebrovascular Disorders; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis, Relapsing-Remitting; Parturition; Pregnancy; Syndrome; Vasoconstriction | 2015 |
Fingolimod and multiple sclerosis: four cautionary tales.
Topics: Antibodies, Monoclonal, Humanized; Brain; Cerebrovascular Disorders; Encephalitis, Varicella Zoster; Female; Fingolimod Hydrochloride; Herpes Zoster; Humans; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Male; Multiple Sclerosis; Natalizumab; Nerve Fibers, Myelinated; Propylene Glycols; Sphingosine | 2012 |
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Topics: Brain; Cerebrovascular Disorders; Encephalitis, Varicella Zoster; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Propylene Glycols; Sphingosine | 2012 |